CDK2 inhibitors (Jiangnan University/China Pharmaceutical University)

N/A

Report date: 2025/03/19 08:57:01
NME

Base Information

Drug NameCDK2 inhibitors (Jiangnan University/China Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesJiangnan UniversityChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A